Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 4Phase 1/2 4Phase 3 3Phase 1 2Phase 4 1Phase 2/3 1

Status

Completed 4Withdrawn 3Terminated 3Recruiting 2Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 264Carcinoma, Non-Small-Cell Lung 219Neoplasms 218Leukemia, Myeloid, Acute 193Multiple Myeloma 178Colorectal Neoplasms 175Melanoma 165Prostatic Neoplasms 163Lymphoma 145Leukemia 142Lymphoma, Non-Hodgkin 133Glioblastoma 131Pancreatic Neoplasms 127Neoplasm Metastasis 118Lung Neoplasms 118Leukemia, Lymphocytic, Chronic, B-Cell 118Ovarian Neoplasms 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Recurrence 97Myelodysplastic Syndromes 93Hodgkin Disease 92Lymphoma, Large B-Cell, Diffuse 89Lymphoma, Follicular 89Lymphoma, Mantle-Cell 83Head and Neck Neoplasms 79Carcinoma, Renal Cell 79Brain Neoplasms 77Sarcoma 73Carcinoma, Hepatocellular 73Squamous Cell Carcinoma of Head and Neck 71

Interventions

monoclonal antibody YYB-101 1Vemurafenib 1Irinotecan 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Colorectal Cancer Metastatic × Clear all
NCT03439462 2024-01-02

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

Aadi Bioscience, Inc.

Phase 1/2 Completed
60 enrolled 14 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT04790448 2023-02-15

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 1/2 Completed
37 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT04368507 2022-11-14

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

CellabMED

Phase 1/2 Completed
35 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03531632 2022-02-08

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

MacroGenics

Phase 1/2 Completed
38 enrolled 12 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡